TrialRMD open2025

Identification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies.

Dafna Gladman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.